Overall rank by patents
#30,335
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Thuasne
USPTO PatentsView assignee record - 9 granted patents across 9 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
9
Total patents granted
9
CPC technology areas
18.4
Avg claims per patent
+25%
5-year filing velocity
The verdict
Thuasne holds 9 US patents across 9 technology areas, rank #30,335 of 50,000 tracked assignees.
- #30,335
- of 50,000 US assignees by volume
- Top 52%
- by Innovation Score (34.6/100)
- 18.4
- avg claims per patent
- +25%
- filing velocity, last 5 yrs
Portfolio overview
Thuasne has been granted 9 US utility patents between 2017 and 2025, placing Thuasne at rank #30,335 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.4 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, Thuasne is one of the more focused assignees in the PatentsView dataset. By volume, Thuasne sits between Thinxtream Technologies PTE. Ltd. (9 patents, rank #30,331) and TLI Inc. (9 patents, rank #30,339) - the closest US assignees by grant volume. The composite Innovation Score of 34.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 4 in the 2015–2019 window, a +25% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Thuasne's 18.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Thuasne against peers pursuing similar technology classes.
Who files at Thuasne's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Thinxtream PTE
THINXTREAM TECHNOLOGIES PTE. LTD.
9 patents
- Thorium Power
THORIUM POWER, INC.
9 patents
- Thorne Intellectu…
THORNE INTELLECTUAL PROPERTY HOLDINGS LLC
9 patents
- Three Smith Group
THREE SMITH GROUP LIMITED
9 patents
- Tianjin Asymchem…
TIANJIN ASYMCHEM PHARMACEUTICALS CO., LTD.
9 patents
- Tianjin Tianchuan…
TIANJIN TIANCHUANG BEST PURE ENVIRONMENTAL SCIENCE AND TECHNOLOGY CO., LTD.
9 patents
- Tinavi Medical
TINAVI MEDICAL TECHNOLOGIES CO., LTD
9 patents
- TLI
TLI INC.
9 patents
- Thuasne ◀
THUASNE
9 patents
What this shows Thuasne holds 9 patents at rank #30,335, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Thuasne
By rank, the assignees closest to #30,335 in granted patent volume.
- Thinxtream Technologies PTE. Ltd. #30,331 · 9 patents
- Thorium Power, Inc. #30,332 · 9 patents
- Thorne Intellectual Property Holdings Llc #30,333 · 9 patents
- Three Smith Group Limited #30,334 · 9 patents
- Tianjin Asymchem Pharmaceuticals Co., Ltd. #30,336 · 9 patents
- Tianjin Tianchuang BEST PURE Environmental Science AND Technology Co., Ltd. #30,337 · 9 patents
- Tinavi Medical Technologies Co., Ltd #30,338 · 9 patents
- TLI Inc. #30,339 · 9 patents
Leaders in A61F (Filters Implantable INTO Blood Vessels)
Other assignees with the most granted patents in Thuasne's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- Depuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- COOK Medical Technologies Llc 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien Lp 528 in class
Thuasne's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
35 Top 52% higher than 48% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 11.1% |
| 2019 | 3 | 33.3% |
| 2021 | 1 | 11.1% |
| 2024 | 3 | 33.3% |
| 2025 | 1 | 11.1% |
Which technologies does Thuasne patent most?
Top 9 of 9 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Growing
Frequently Asked Questions
How many patents does Thuasne hold?
Thuasne holds 9 US granted patents filed between 2017 and 2025, spanning 9 technology areas.
What is Thuasne's Innovation Score?
Thuasne has an Innovation Score of 34.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Thuasne focus on?
Thuasne's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 8 patents. The company has filed patents in 9 CPC subclasses total.
Is Thuasne's patent filing rate increasing or decreasing?
Thuasne's recent filing velocity is +25% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Thuasne's patents?
Thuasne's patents average 18.4 claims each. This falls within the standard range, providing solid legal coverage.
How is the Thuasne patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Thuasne's 9 grants land it in the top 52% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Thuasne ranks #30,335 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.